On January 20, 2015, a required bankruptcy report regarding motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Natural Molecular Testing Corporation and its affiliates.
The filing was assigned docket number 495 and is described on the court’s official docket as follows:
Trustee’s Report RE: Submission of Proposed Order and Asset Purchase Agreement (MedTech).. Filed by John S Kaplan on behalf of Mark Calvert. (Related document(s)429 Motion to Sell Free and Clear of Liens). (Attachments: # 1 Proposed Order # 2 Exhibit A – to Proposed Order – Asset Purchase Agreement (MedTech)) (Kaplan, John) (Entered: 01/20/2015 at 11:15:34)
Natural Molecular Testing Corporation filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 21, 2013. The bankruptcy case is pending before the United States Bankruptcy Court for the Western District of Washington . The case number for the lead bankruptcy case is 13-19298. The bankruptcy case is currently assigned to United States Bankruptcy Judge Karen Overstreet. The law firm of Hacker & Willig, Inc., P.S. is acting as lead bankruptcy counsel to Natural Molecular Testing Corporation in the bankruptcy case.